Reihane Taheri
Spencer D. Proctor*- Metabolic and Cardiovascular Diseases Laboratory, Division of Human Nutrition, University of Alberta, Edmonton, AB, Canada
Editorial on the Research Topic
Effect of overweight/obesity on early puberty and related chronic disease risk factors
Clinical problem
Obesity is often defined as those with excessive or abnormal body fat that in turn contributes to associated comorbidities; some of these include; Alzheimer’s disease, cardiovascular disease (CVD), respiratory disease, autoimmunity, diabetes, some cancers (prostate, ovarian, breast and colon), non-alcoholic fatty liver disease (NAFLD), and osteoarthritis (1–3). As a result, obesity is ranked as 5th leading cause of death globally (1).
The World Health Organization (WHO) report in 2016 indicated that the prevalence of overweight and obesity in children and adolescents (aged 5-19) quadrupled from 4% in 1975 to 18% in 2016 (2). The exact cause of obesity is multifactorial, but it is the combined result of energy imbalance due to complex interactions between genetic and behavioural risk factors such as diet, physical activity, psychosocial factors (4). Childhood obesity typically associates with emerging medical problems such as the metabolic syndrome (MetS), puberty disorders, NAFLD, as well as sleep apnea during developmental stages (5). Importantly, we know that children with obesity are at higher risk of obesity in adulthood as well as future cardiometabolic diseases (6, 7). There are further implications to youth with obesity including the development of early social and emotional consequences (5, 8). Due to the importance of childhood obesity, Journal of Frontiers in Endocrinology has chosen to call this Research Topic to discuss recent findings in the area.
Energy expenditure and physical activity
Reduced physical activity, especially in children, has been considered as one of the initiating factors contributing to increased prevalence of obesity (9). However, in this Research Topic Le et al. rightly voiced that the relation of physical activity with maintaining healthy weight during adolescence is complicated. For example, it remains to be resolved whether leisure-time physical activity (LTPA) is directly associated with future BMI or fat mass in adolescents. At the same time, vigorous physical activity during adolescence has been shown to be associated with a reduced BMI at early adulthood, but only in boys. These observations highlight that during adolescence, the level of fatness (but not necessarily physical activity) maybe a predictor of future adiposity. It is also critical to appreciate that the relation of physical activity and fat mass varies among boys and girls depending on the pubertal status.
Non-alcoholic fatty liver disease
Obesity is commonly associated with an increased risk of NAFLD and MetS during adolescence (10, 11). MetS is characterized by high fasting plasma glucose, insulin resistance, dyslipidemia, high blood pressure and obesity. These clinical features are also seen in patients with NAFLD (now also known as Metabolic dysfunction-Associated SteatoHepatitis or MASH). NAFLD is the most common cause of chronic liver disease in children and adolescents that tracks with liver disease in adulthood (3, 10, 12). In this Research Topic, Zhou et al. highlighted that high BMI is perhaps the greatest risk factor for NAFLD incidence in children. Their study found that in children with obesity (prior late puberty), the most significant risk factors for NAFLD included BMI, alanine transaminase (ALT), and age. Interestingly, they found that the greatest risk exposures for NAFLD in children were BMI and ALT. Of course, the early diagnosis of dysglycemia, dyslipidemia and obesity are now critical to protect children from developing both MetS and NAFLD. In terms of dyslipidemia, traditional lipid biomarkers used for MetS diagnosis are high triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C). However, plasma TC and LDL-C levels often drop physiologically during puberty (13). For example, in a study in Canada, reported that adolescents with obesity can have relatively normal level of classic lipid levels while still presenting with cardiometabolic risk and high apo-lipoprotein B levels (14). A better understanding of these non-traditional lipid biomarkers during adolescence would be useful in this clinical context. In this Research Topic, Chen et al. compared the association of adolescents with MetS with both traditional and non-traditional biomarkers including apo-B lipoprotein, non-HDL-C, and lipid accumulation product (LAP). Their study highlighted that most of these lipid biomarkers are closely associated with MetS in youth. Curiously, LAP had the closest association with the risk of MetS. LAP can be readily calculated by measuring both the waistline and blood concentrations of TG. Advancing the clinical usefulness of non-tradition lipid biomarkers may indeed be the path by which we can improve our early diagnosis metabolic dysfunction in those youth with obesity.
Early obesity and hormonal interactions
Childhood obesity is known to affect the onset of puberty during adolescence. Studies have reported that obese girls have a greater susceptibility to precocious puberty in comparison to normal-weight girls, but this association is less clear in boys (8). In this Research Topic, the longitudinal study by Choe et al. found that rapid weight gain during infancy (birth-12 months) and toddlerhood (1-to 3 years old) is not associated with early central precocious puberty (CPP) in boys. In contrast, girls who experienced rapid weight gain during both infancy and toddlerhood had the highest increased risk of (CPP). These findings suggest that early detection of excessive weight gain, especially during infancy, maybe essential to prevent future CPP in girls. However, obesity is not the only risk factor associated with early onset of puberty (15). Here, Tang et al. showed that after adjustment of BMI, dietary patterns, soft drink, feeding pattern and mother’s BMI, short sleep duration, were all associated with early pubertal development in both girls and boys. Researchers attempted to find ways to prevent obesity and precocious puberty in different ways including use of nutrients. One of the beneficial nutrients proposed to be effective in prevention of obesity and obesity-related precocious puberty is (-)-Epigallocatechin-3-gallate (EGCG), the most abundant catechin in tea. In order to find out the mechanism which EGCG affects puberty, Gu et al. assessed the metabolites involved in endocrine-related pathways (estrogen signaling pathway, insulin resistance, and insulin secretion), and signal transduction (PI3K-Akt, MAPK, and Jak-STAT signaling pathways). They found that the potential protective effect of EGCG is related to both endocrine and signal transduction pathways. For example, EGCG can target multiple signaling pathways, including estrogen, PI3K-Akt, MAPK, and Jak-STAT pathways. This study provided foundation for future research using EGCG for treatment of obesity and precocious puberty.
Final comments
Childhood obesity is a major risk factor for developing chronic diseases in adulthood. The development of obesity in childhood and adolescence is complex and multifactorial. Advancing this field remains critical for us to better understand prevention measures and clinical parameters that will aid in the early detection and resolution of this trajectory.
Author contributions
SP: Writing – original draft, Writing – review & editing. RT: Writing – original draft, Writing – review & editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi’i A. A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med (2021) 136:104754. doi: 10.1016/j.compbiomed.2021.104754
2. WorldHealthOrganization. Obesity and overweight (2021). Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
3. Scapaticci S, D’Adamo E, Mohn A, Chiarelli F, Giannini C. Non-alcoholic fatty liver disease in obese youth with insulin resistance and type 2 diabetes. Front Endocrinol (2021) 12:639548. doi: 10.3389/fendo.2021.639548
4. Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J managed Care (2016) 22(7 Suppl):s176–85.
5. Sahoo K, Sahoo B, Choudhury AK, Sofi NY, Kumar R, Bhadoria AS. Childhood obesity: causes and consequences. J Family Med primary Care (2015) 4(2):187–92. doi: 10.4103/2249-4863.154628
6. Rao DP, Kropac E, Do MT, Roberts KC, Jayaraman GC. Childhood overweight and obesity trends in Canada. Health promotion chronic Dis Prev Canada: research Policy practice (2016) 36(9):194–8. doi: 10.24095/hpcdp.36.9.03
7. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med (2011) 365(20):1876–85. doi: 10.1056/NEJMoa1010112
8. Huang A, Reinehr T, Roth CL. Connections between obesity and puberty: invited by manuel tena-sempere, cordoba. Curr Opin endocrine Metab Res (2020) 14:160–8. doi: 10.1016/j.coemr.2020.08.004
9. Colley RC, Clarke J, Doyon CY, Janssen I, Lang JJ, Timmons BW, et al. Trends in physical fitness among Canadian children and youth. Health Rep (2019) 30(10):3–13. doi: 10.25318/82-003-x201901000001-eng
10. Lee MK, Han K, Kim MK, Koh ES, Kim ES, Nam GE, et al. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci Rep (2020) 10(1):2313. doi: 10.1038/s41598-020-59203-z
11. Rong Y, Chun-Yan N, Hong-Xin Z, Lu Y, Wen W, Yu T. Association of adolescent obesity with nonalcoholic fatty liver disease and related risk factors in xi A’n, China. Ann Hepatol. (2018) 17(1):85–91. doi: 10.5604/01.3001.0010.7538
12. Aboonabi A, Meyer RR, Singh I. The association between metabolic syndrome components and the development of atherosclerosis. J Hum Hypertens (2019) 33(12):844–55. doi: 10.1038/s41371-019-0273-0
13. Eissa MA, Mihalopoulos NL, Holubkov R, Dai S, Labarthe DR. Changes in fasting lipids during puberty. J Pediatr (2016) 170:199–205. doi: 10.1016/j.jpeds.2015.11.018
14. Krysa JA, Ball GDC, Vine DF, Jetha M, Proctor SD. ApoB-lipoprotein remnant dyslipidemia and high-fat meal intolerance is associated with markers of cardiometabolic risk in youth with obesity. Pediatr Obes (2021) 16(5):e12745. doi: 10.1111/ijpo.12745
Keywords: obesity, youth, chronic disease, diabetes, dyslipidemia
Citation: Taheri R and Proctor SD (2024) Editorial: Effect of overweight/obesity on early puberty and related chronic disease risk factors. Front. Endocrinol. 15:1357819. doi: 10.3389/fendo.2024.1357819
Received: 18 December 2023; Accepted: 16 January 2024;
Published: 25 January 2024.
Edited and Reviewed by:
Sally Radovick, Rutgers, The State University of New Jersey, United StatesCopyright © 2024 Taheri and Proctor. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Spencer D. Proctor, c3BlbmNlci5wcm9jdG9yQHVhbGJlcnRhLmNh